Swiss biotech Oculis is advancing its drug candidate, privosegtor (OCS-05), into pivotal Phase 3 trials for acute optic neuritis (AON) and non-arteritic anterior ischemic optic neuropathy (NAION)
The goal is to reduce side effects, improve tolerance, and lower treatment costs while still getting the metabolic benefits
Lan KC, Lai YJ, Cheng HH, Tsai NC, Su YT, Tsai CC et al (2020) Levels of sex steroid hormones and their receptors in women with preeclampsia
Specifically, it depends on transporters called GLUT4, or glucose transporter type 4
Answer: Many surgeons recommend stopping GLP-1 medications two to three weeks before surgery due to delayed gastric emptying concerns
Who Is Tirzepatide 100mg Best For